Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2026-04-30 @ 8:37 PM
Study NCT ID:
NCT06180993
Status:
RECRUITING
Last Update Posted:
2023-12-26
First Post:
2023-12-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of the Effectiveness and Impact of Nirsevimab Administered as Routine Immunization
Sponsor:
Federico Martinón Torres
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
NIRSE-GAL
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None